UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Alterations in the Von Willebrand Factor/ADAMTS13 axis in preeclampsia

Neave, Lucy; Thomas, Mari; de Groot, Rens; Doyle, Andrew J; Singh, Deepak; Adams, George; David, Anna L; ... Scully, Marie; + view all (2023) Alterations in the Von Willebrand Factor/ADAMTS13 axis in preeclampsia. Journal of Thrombosis and Haemostasis 10.1016/j.jtha.2023.10.022. (In press).

[thumbnail of Neave et al_ VWF ADAMTS13 in preeclampsia. Revised clean.pdf] Text
Neave et al_ VWF ADAMTS13 in preeclampsia. Revised clean.pdf - Accepted Version
Access restricted to UCL open access staff until 5 July 2024.

Download (553kB)

Abstract

BACKGROUND: Preeclampsia is a gestational hypertensive disorder, characterised by maternal endothelial activation, and increased ratio of soluble fms-like tyrosine kinase inhibitor-1 (sFlt-1) to placental growth factor (PlGF). The von Willebrand Factor (VWF)/ADAMTS13 axis is of interest because of the underlying endothelial activation, and clinical overlap with pregnancy-associated thrombotic thrombocytopenic purpura. OBJECTIVES: To assess VWF, ADAMTS13, and VWF/ADAMTS13 ratio in preeclampsia, and look for associations with sFlt-1/PlGF ratio, and clinical features. PATIENTS/METHODS: 34 preeclampsia cases and 48 normal pregnancies were assessed in a case-control study. 12 normal pregnancies in women with a history of preeclampsia formed an additional comparator group. VWF antigen (VWF:Ag) and activity (VWF:Ac (VWF:GPIbM)) were measured via automated immunoturbidimetric assay; ADAMTS13 activity via FRETS-VWF73 assay; and sFlt-1 and PlGF via ELISA. RESULTS: VWF:Ag was higher in preeclampsia than normal pregnancy (median 3.07 vs 1.87 iu/ml, P<0.0001). ADAMTS13 activity was slightly lower (89.6 vs 94.4 iu/dl, P=0.02), with no severe deficiencies. Significant elevations in VWF:Ac were not observed in preeclampsia, resulting in reduced VWF:Ac/VWF:Ag ratios (0.77 vs 0.97, P <0.0001). VWF:Ag/ADAMTS13 ratios were significantly higher in preeclampsia (3.42 vs 2.06, P <0.0001), with adjusted odds ratio of 19.2 for ratio>2.7 (>75th centile of normal pregnancy). Those with a history of preeclampsia had similar ratios to normal pregnant controls. VWF:Ag/ADAMTS13 and sFlt-1/PlGF were not correlated. However, % fall in platelets correlated positively with VWF:Ac (P=0.01); VWF:Ac/VWF:Ag ratio (P=0.004), and sFlt-1/PlGF ratio (P=0.01). CONCLUSIONS: The VWF/ADAMTS13 axis is significantly altered in preeclampsia. Further investigation of potential clinical utility is warranted.

Type: Article
Title: Alterations in the Von Willebrand Factor/ADAMTS13 axis in preeclampsia
Location: England
DOI: 10.1016/j.jtha.2023.10.022
Publisher version: http://dx.doi.org/10.1016/j.jtha.2023.10.022
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: ADAMTS13, angiogenic imbalance, Preeclampsia, thrombocytopenia, von Willebrand factor
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health > Maternal and Fetal Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Pre-clinical and Fundamental Science
URI: https://discovery.ucl.ac.uk/id/eprint/10185132
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item